Literature DB >> 25112529

Shaping of an effective immune microenvironment to and by cancer cells.

Etienne Becht1, Jeremy Goc, Claire Germain, Nicolas A Giraldo, Marie-Caroline Dieu-Nosjean, Catherine Sautès-Fridman, Wolf-Herman Fridman.   

Abstract

A high density of intratumoral effector memory CD8+/Th1 T cells is associated with favorable prognosis in most cancers and may be induced or increased by immunotherapy. Efficient adaptive immune reactions are shaped in tumor adjacent tertiary lymphoid structures, which exhibit all characteristics of immunity generating lymphoid formations in reactive lymph nodes. Malignant tumor cells impact favorably or deleteriously their immune microenvironment if they bear genetic mutations that result in neo-antigens or by producing chemokines and cytokines that recruit lymphocytes and myeloid cells or increase inflammation and neo-angiogenesis. This intricate network of interactions results in control or escape of tumors, and its understanding will help define goals to monitor efficiency of immunotherapies.

Entities:  

Mesh:

Year:  2014        PMID: 25112529     DOI: 10.1007/s00262-014-1590-3

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  11 in total

1.  mRNA Expression levels of genes involved in antitumor immunity: Identification of a 3-gene signature associated with prognosis of muscle-invasive bladder cancer.

Authors:  Constance Le Goux; Sophie Vacher; Géraldine Pignot; Mathilde Sibony; Nicolas Barry Delongchamps; Benoit Terris; Eliane Piaggio; Marc Zerbib; Diane Damotte; Ivan Bieche
Journal:  Oncoimmunology       Date:  2017-08-14       Impact factor: 8.110

Review 2.  The immune response in cancer: from immunology to pathology to immunotherapy.

Authors:  Nicolas A Giraldo; Etienne Becht; Yann Vano; Catherine Sautès-Fridman; Wolf H Fridman
Journal:  Virchows Arch       Date:  2015-06-16       Impact factor: 4.064

3.  CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.

Authors:  H Zhang; Y-L Ye; M-X Li; S-B Ye; W-R Huang; T-T Cai; J He; J-Y Peng; T-H Duan; J Cui; X-S Zhang; F-J Zhou; R-F Wang; J Li
Journal:  Oncogene       Date:  2016-10-10       Impact factor: 9.867

4.  Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC).

Authors:  Etienne Becht; Nicolas A Giraldo; Benoit Beuselinck; Sylvie Job; Laetitia Marisa; Yann Vano; Stéphane Oudard; Jessica Zucman-Rossi; Pierre Laurent-Puig; Catherine Sautès-Fridman; Aurélien de Reyniès; Wolf Herman Fridman
Journal:  Oncoimmunology       Date:  2015-08-07       Impact factor: 8.110

5.  Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma.

Authors:  Ombretta Melaiu; Marco Chierici; Valeria Lucarini; Giuseppe Jurman; Libenzio Adrian Conti; Rita De Vito; Renata Boldrini; Loredana Cifaldi; Aurora Castellano; Cesare Furlanello; Vincenzo Barnaba; Franco Locatelli; Doriana Fruci
Journal:  Nat Commun       Date:  2020-11-25       Impact factor: 14.919

6.  CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.

Authors:  Depei Li; Wanming Hu; Xiaoping Lin; Ji Zhang; Zhenqiang He; Sheng Zhong; Xia Wen; Peiyu Zhang; Xiaobing Jiang; Hao Duan; Chengcheng Guo; Jian Wang; Jing Zeng; Zhongping Chen; Yonggao Mou; Ke Sai
Journal:  Front Cell Dev Biol       Date:  2021-03-19

7.  Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand.

Authors:  Xavier Préville; Karola Rittner; Laetitia Fend
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

Review 8.  Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer.

Authors:  Jitka Fucikova; Irena Moserova; Linda Urbanova; Lucillia Bezu; Oliver Kepp; Isabelle Cremer; Cyril Salek; Pavel Strnad; Guido Kroemer; Lorenzo Galluzzi; Radek Spisek
Journal:  Front Immunol       Date:  2015-08-07       Impact factor: 7.561

9.  Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathway.

Authors:  Ciputra Adijaya Hartana; Emma Ahlén Bergman; A Ali Zirakzadeh; David Krantz; Malin E Winerdal; Max Winerdal; Markus Johansson; Farhood Alamdari; Tomasz Jakubczyk; Hans Glise; Katrine Riklund; Amir Sherif; Ola Winqvist
Journal:  PLoS One       Date:  2018-07-02       Impact factor: 3.240

Review 10.  Site-specific metastasis: A cooperation between cancer cells and the metastatic microenvironment.

Authors:  Sivan Izraely; Isaac P Witz
Journal:  Int J Cancer       Date:  2020-08-27       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.